Abstract: A method and device for modulating the autonomic nervous system adjacent a pericardial space to treat cardiac arrhythmia includes a treatment source arranged to supply a treatment medium, a catheter having an end sized for insertion into the pericardial space, a medium delivery assembly having a distal end arranged to be positioned by the catheter into the pericardium, with the distal end of the delivery assembly comprising a delivery tip arranged to extend away from the distal end of the catheter into the pericardial space. A connector operatively couples the delivery tip of the medium delivery assembly to the treatment source, and the delivery tip of the medium delivery assembly including a plurality of delivery points for delivering the treatment medium at a plurality of treatment areas within the pericardial space. The device performs modulation or ablation of the autonomic nervous system at selected treatment areas within the pericardium.

Abstract: Provided herein is technology for breast cancer screening and particularly, but not exclusively, to methods, compositions, and related uses for detecting the presence of breast cancer.

Abstract: Embodiments of the invention include a breast nipple areola complex tattoo stencil comprising first, second and third stencil sections. The first stencil section defines an areola area. The second stencil section defines a nipple area and tubercle areas. One or more registration elements on the first and/or second stencil sections enable registration of the second stencil section to the first stencil section. The third stencil section defines one or both of a nipple shading area and a nipple highlight area. One or more registration elements on the third and/or second stencil sections enable registration of the third stencil section to the second stencil section.

Abstract: Described herein are compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic. Also described are lyophilized compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic.

Abstract: This document provides methods and materials for treating cancer (e.g., chemotherapeutic resistant cancer). For example, compositions containing a phosphorylation-mimicking peptide (e.g., a phosphorylation-mimicking FOXO1-derived peptide) to treat a mammal having cancer (e.g., to reduce the number of cancer cells in a mammal) and methods of using such compositions are provided. This document also provides methods of treating a mammal having cancer (e.g., to reduce the number of cancer cells in a mammal) by administering a phosphorylation-mimicking FOXO1-derived peptide to the mammal.

Abstract: This document relates to materials and methods for identifying and monitoring immunoglobulin cleavage (e.g., IgG cleavage) in a sample, such as a biological sample, using mass spectrometry techniques.

Abstract: A radial head prosthesis for implantation in a distal radius. The implant includes a head portion and a stem portion. The stem portion has a cylindrical shaft and tapered tip. The head portion includes a recess for engagement with the stem portion. The head portion includes a first bearing surface for articulation with a humerus, and a second bearing surface for articulation with an ulna. The second bearing surface includes at least one concave and one convex portion immediately adjacent one another.

Abstract: This document provides methods and materials for treating diabetes. For example, methods and materials for using nucleic acid encoding human preproinsulin to treat diabetes (e.g., type I or type II diabetes) are provided.

Abstract: This document provides methods and materials related to assessing immunity to folate receptors. For example, methods and materials for assessing FR? immunity in a mammal are provided. This document also provides methods and materials related to stimulating immunity to folate receptors.

Abstract: This document relates to methods and materials for assessing and/or treating obese mammals (e.g., obese humans). For example, methods and materials for using one or more interventions (e.g., one or more pharmacological interventions) to treat obesity and/or obesity-related comorbidities in a mammal (e.g., a human) identified as being likely to respond to a particular intervention (e.g., a pharmacological intervention) are provided.

Abstract: Systems and methods for impairing smooth muscle tissue function using energy and/or pressure are described herein. The systems and/or methods may be used in some embodiments to target smooth muscle tissue in the bronchial passages.

Abstract: A method and composition for treating a meningioma in a subject are disclosed. The method includes the step of administering to the subject a therapeutically effective amount of a composition including a cytotoxic agent associated with a phenylbenzothiazole derivative or a stilbene derivative or a biphenylalkyne derivative that accumulates within meningiomas.

Abstract: Devices described herein can be used to directly measure left atrial pressure. For example, this document describes multiple embodiments of catheter-based, trans-esophageal tonometry devices that are used to directly measure left atrial pressure in a non-invasive manner.

Abstract: Cystic lesions can be treated by electroporation. For example, this document describes methods and devices for endoscopic ultrasound-guided ablation of cystic lesions using a needle for electroporation.

Abstract: Provided herein is technology for prostate cancer screening and particularly, but not exclusively, to methods, compositions, and related uses for detecting the presence of prostate cancer.

Abstract: Provided herein is technology for breast cancer screening and particularly, but not exclusively, to methods, compositions, and related uses for detecting the presence of breast cancer.

Abstract: This specification describes systems, methods, devices, and other techniques for activating muscle groups in a mammal using an implantable epidural electrical stimulation (EES) system, and for using spinal landmarks to determine implant locations for an EES probe. In some aspects, a first set of electrodes of an EES system is provided at a first set of locations on the dura mater of a spine of a mammal, the first set of locations on the dura mater corresponding to a first muscle group of the mammal, a second set of electrodes is provided at a second set of locations on the dura mater of the spine of the mammal, the second set of locations on the dura mater corresponding to a second muscle group of the mammal, and the first and second sets of locations on the dura mater are stimulated by electrically energizing the first and second sets of electrodes.

Abstract: This document provides methods and materials relating to platelet lysates. For example, methods and materials for using platelet lysate compositions to grow adult stem cells, to differentiate adult stem cells, to grow primary cell cultures, to grow tumor stem cells, and to identify effective growth factors are provided.

Abstract: Non-invasive systems can be used to estimate cardiac output and stroke volume. For example, this document provides cuff occlusion systems and methods for their use so that cardiac output and stroke volume can be estimated in a non-invasive fashion. In some implementations, a patient's brachial artery is occluded by an inflatable cuff device for a period of time. A heart rate and a plurality of blood pressure pulse wave measurement curves can be measured using the cuff device. The data collected can be used to calculate an estimate of the patient's cardiac output and stroke volume.

Abstract: A surgical system includes a skull attachment device that includes a support base configured to seat against a skull of a patient and one or more pins extending from a bottom surface of the support base and configured to pierce the scalp to seat the skull attachment device against the skull. The surgical system also includes an interface disposed along a top surface of the support base and having a shape that compliments a profile of a mating feature of a stereotactic device for defining a position and an orientation of the stereotactic device with respect to the support base while the interface is engaged with the mating feature.